SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Date of Report (Date of Earliest Event Reported): October 9, 2000
----------------
VITRO DIAGNOSTICS, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Nevada 0-17378 84-1012042
---------------- ------------ -------------------
(State or other (Commission (I.R.S. Employer
jurisdiction of File Number) Identification No.)
incorporation)
8100 Southpark Way, B-1
Littleton, Colorado 80120
---------------------------------------- -------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number including area code: (303) 798-6882
--------------
-------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
Item 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT
On October 9, 2000, Vitro Diagnostics, Inc. (the "Company"), as approved by
the Board of Directors, engaged Cordovano and Harvey, P.C. as its principal
accountant and independent auditors for the fiscal year ending October 31, 2000,
and simultaneously dismissed Larry O'Donnell, CPA, P.C. as its principal
accountant and auditors.
The reports of Larry O'Donnell, CPA, P.C. for the past two fiscal years did
not contain an adverse opinion or a disclaimer of opinion and were not qualified
or modified as to uncertainty, audit scope or accounting principles.
During the Company's two most recent fiscal years and the interim period
through October 9, 2000, there were no disagreements with Larry O'Donnell, CPA,
P.C. on any matter of accounting principles or practices, financial statement
disclosure, or auditing scope and procedure which, if not resolved to the
satisfaction of Larry O'Donnell, CPA, P.C., would have caused Larry O'Donnell,
CPA, P.C. to make reference to the matter in their report. Further, there were
no reportable events as that term is described in Item 304(a)(1)(iv)(B) of
Regulation S-K.
The Company has requested Larry O'Donnell, CPA, P.C. to furnish it a letter
addressed to the Securities and Exchange Commission stating whether it agrees
with the above statements. A copy of the letter, dated October 27, 2000, is
filed as Exhibit 16 to this Form 8-K/A.
During the two most recent fiscal years and the interim period through
October 9, 2000, the Company has not consulted Cordovano and Harvey, P.C.,
regarding any matter requiring disclosure in this Form 8-K/A.
Item 7. FINANCIAL STATEMENTS AND EXHIBITS
a. Not applicable.
b. Not Applicable.
c. Exhibits.
16. Letter, dated October 27, 2000, from former certifying accountant,
Larry O'Donnell, CPA, P.C.
<PAGE>
SIGNATURE
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this Report to be signed on
its behalf by the undersigned hereunto duly authorized.
VITRO DIAGNOSTICS, INC.
Date: October 30, 2000 By: /s/ James R. Musick
-----------------------
James R. Musick, President
<PAGE>
EXHIBIT INDEX
Exhibit
Number Description
16 Letter from Larry O'Donnell, CPA, P.C., dated October 27, 2000.
